Clinical Trials
29 trialsCollection of Blood and Urine From Patients Undergoing Radiation Therapy
National Institutes of Health Clinical Center (CC)
Follow Up Protocol for Subjects Previously Enrolled on NCI Surgery Branch Studies
National Institutes of Health Clinical Center (CC)
FDG Immun Comb
Centre Antoine Lacassagne
dOCT-pBCC
Vejle Hospital
MRinRT
Swansea Bay University Health Board
Oropharynx (OPX) Biomarker Trial
Mayo Clinic
Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastatic Head and Neck Cancer
M.D. Anderson Cancer Center
TraveraRTGx
Travera Inc
BladMetrix
Oslo University Hospital
Nasal Reconstruction FACE-Q : French Validation of the Nasal Reconstruction FACE-Q Questionnaire for Reconstruction/Rehabilitation Following Nasal Skin Cancer
Hôpital NOVO
RELI
Maastricht University Medical Center
(CAN-IMPACT-IO
Canadian Cancer Trials Group
BACAP-2
University Hospital, Toulouse
Evaluation of 'WAYMED Endo CL CS' for Automated Detection and Diagnosis of Colorectal Adenoma and Non-Adenoma Lesions
WAYCEN Inc
Novel Serum Markers for Monitoring Response to Anti-Cancer Therapy
Stanford University
SMARAGD
iOMEDICO AG
PROTEOMASH
University Hospital, Bordeaux
OCAPI
Centre Francois Baclesse
Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)
Jinling Hospital, China
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
Jinling Hospital, China
RO6-HCC
Sohag University
A Screening Study to Collect Samples for TAA, HLA & HLA Loss of Heterozygosity in Patients With Metastatic Solid Tumors
TScan Therapeutics, Inc.
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Massive Bio, Inc.
The Treatment of Unresectable Liver Cancer With E-TACE Combined With Donafenib:A Prospective, Single-arm, Multicenter, Observational Study
The First Affiliated Hospital of Zhengzhou University
RI-NIVO
Azienda USL Reggio Emilia - IRCCS
Exploring Relevant Immune-based Biomarkers and Circulating Tumor Cells During Treatment With Immunotherapy in Genitourinary Malignancies (CTC Immune Based Biomarkers)
Duke University
Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction
Weill Medical College of Cornell University
Prevalence of Fuchs Endothelial Corneal Dystrophy in a Population of Dermatology Patients.
Centre Hospitalier Universitaire de Saint Etienne
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
Memorial Sloan Kettering Cancer Center